Vector-borne diseases (VBDs) represent a significant public health challenge in India, necessitating a comprehensive understanding of their epidemiology, control measures, and impact on the healthcare system.
In India, VBDs such as malaria, dengue, chikungunya, and Japanese encephalitis are widespread. The National Vector Borne Disease Control Programme (NVBDCP) reports millions of cases annually. Factors such as climate change, urbanization, and population movement contribute to the high prevalence and geographic spread of these diseases.
VBDs place a significant burden on India's healthcare system. They cause substantial morbidity and mortality, leading to high healthcare costs and productivity loss. The strain on healthcare resources is especially pronounced during outbreaks, with hospitals often grappling with bed shortages and overworked staff.
Efforts to control VBDs in India include vector control, disease surveillance, early diagnosis and treatment, and public health education. However, challenges such as insecticide resistance, lack of public awareness, and gaps in surveillance and reporting systems persist. The development and implementation of effective vaccines also remain a key area of focus.
Healthcare professionals play a critical role in managing VBDs. They are at the forefront of early diagnosis and treatment, patient education, and advocacy for public health measures. Their understanding of the epidemiology and control of VBDs is essential for effective disease management and control.
The burden of VBDs in India is substantial, with significant implications for the healthcare system. Comprehensive understanding and strategic interventions are crucial to mitigate this public health challenge. Healthcare professionals, with their pivotal role, are key to achieving this goal.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation